当前位置:循环首页>正文

贝特类和他汀联合应用降低T2DM剩余心血管风险——Alberto Zambon教授专访

作者:国际循环网   日期:2011/7/14 11:28:16

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

The risk of macro and micro-vascular complications remains consistently high even under the best standard of care.

  International Circulation: Residual risks for T2DM patients are much higher compared to non diabetics even on high anti-hypertensive hypoglycemic and LDL-C reduction therapy, what are the reasons for this?
  Prof Alberto Zambon: The risk of macro and micro-vascular complications remains consistently high even under the best standard of care. The reason for this is that there are macro and micro-vascular complications we can modify and then there are those we cannot modify. We will never reduce the risk of these complications down to zero. On the other hand those complications which are modifiable are definitely under treated and this is one of the reasons why they remain high in T2DM patients.
  International Circulation: What’s the relationship between T2DM and atherogenic dyslipidemia? Why is atherogenic dyslipidemia more dangerous in T2DM patients?
  Prof Alberto Zambon: The risk of atherogenic dyslipidemia is consistently high because it is a major component of the pathophysiological pathway that leads to insulin resistance. What is atherogenic dyslipidemia? It is the reduction in the bodies good cholesterol, increased levels of triglycerides and even though levels of the bad cholesterol (LDL) in most of the times are only mildly elevated, the lipoproteins that carry the LDL cholesterol are particularly nasty because they are small, dense and easily oxidized. Collectively, these factors make them dangerous for the arterial wall.

[1]  [2]  下一页

版面编辑:赵书芳  责任编辑:其他


TG LDL-C他汀心血管剩余风险贝特类T2DM

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530